{
  "7MW-3711": null,
  "9MW-2921": null,
  "ABBV-011": {
    "Input Name": "ABBV-011",
    "Found": true,
    "Primary Target Name": "TNF-alpha",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297572",
      "Preferred Name": "ABBV-3373",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "TNF-alpha binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1825",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Glucocorticoid receptor modulator",
        "Action Type": "MODULATOR",
        "Target ChEMBL ID": "CHEMBL2034",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000685",
        "EFO Term": "rheumatoid arthritis",
        "MeSH ID": "D001172",
        "MeSH Term": "Arthritis, Rheumatoid",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2034",
        "Pref Name": "Glucocorticoid receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04150",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P04150",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1825",
        "Pref Name": "TNF-alpha",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P01375",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0010628",
            "HGNC": "positive regulation of gene expression"
          }
        ]
      }
    ]
  },
  "ABBV-319": {
    "Input Name": "ABBV-319",
    "Found": true,
    "Primary Target Name": "TNF-alpha",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297572",
      "Preferred Name": "ABBV-3373",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "TNF-alpha binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1825",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Glucocorticoid receptor modulator",
        "Action Type": "MODULATOR",
        "Target ChEMBL ID": "CHEMBL2034",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000685",
        "EFO Term": "rheumatoid arthritis",
        "MeSH ID": "D001172",
        "MeSH Term": "Arthritis, Rheumatoid",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2034",
        "Pref Name": "Glucocorticoid receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04150",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P04150",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1825",
        "Pref Name": "TNF-alpha",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P01375",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0010628",
            "HGNC": "positive regulation of gene expression"
          }
        ]
      }
    ]
  },
  "ABBV-706": null,
  "ABBV-969": null,
  "ABBV\u2011400": {
    "Input Name": "ABBV\u2011400",
    "Found": true,
    "Primary Target Name": "TNF-alpha",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297572",
      "Preferred Name": "ABBV-3373",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "TNF-alpha binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1825",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Glucocorticoid receptor modulator",
        "Action Type": "MODULATOR",
        "Target ChEMBL ID": "CHEMBL2034",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000685",
        "EFO Term": "rheumatoid arthritis",
        "MeSH ID": "D001172",
        "MeSH Term": "Arthritis, Rheumatoid",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2034",
        "Pref Name": "Glucocorticoid receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04150",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P04150",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1825",
        "Pref Name": "TNF-alpha",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P01375",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0010628",
            "HGNC": "positive regulation of gene expression"
          }
        ]
      }
    ]
  },
  "ABV-706": null,
  "ACR-246": null,
  "ADC-2122": null,
  "ADCE-T02": null,
  "ADCE\u2011D01": null,
  "ADCT-701": null,
  "ADCT-901": null,
  "ADCT\u2011241": null,
  "ADCT\u2011242": null,
  "ADRX-0405": null,
  "ADRX-0706": {
    "Input Name": "ADRX-0706",
    "Found": true,
    "Primary Target Name": "Tyrosine-protein kinase ABL",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4130229",
      "Preferred Name": "VODOBATINIB",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-tinib",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tyrosine-protein kinase ABL inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1862",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Bcr/Abl fusion protein inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2096618",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000339",
        "EFO Term": "chronic myelogenous leukemia",
        "MeSH ID": "D015464",
        "MeSH Term": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "HP:0000726",
        "EFO Term": "Dementia",
        "MeSH ID": "D003704",
        "MeSH Term": "Dementia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0005180",
        "EFO Term": "Parkinson disease",
        "MeSH ID": "D010300",
        "MeSH Term": "Parkinson Disease",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005772",
        "EFO Term": "neurodegenerative disease",
        "MeSH ID": "D019636",
        "MeSH Term": "Neurodegenerative Diseases",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004643",
        "EFO Term": "myeloid leukemia",
        "MeSH ID": "D007951",
        "MeSH Term": "Leukemia, Myeloid",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1862",
        "Pref Name": "Tyrosine-protein kinase ABL",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P00519",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P00519",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2096618",
        "Pref Name": "Bcr/Abl fusion protein",
        "Target Type": "CHIMERIC PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P00519",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P00519",
            "HGNC": null
          },
          {
            "Accession": "P11274",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11274",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "AGX-101": null,
  "AK-138D1": {
    "Input Name": "AK-138D1",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297481",
      "Preferred Name": "AK-106",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000685",
        "EFO Term": "rheumatoid arthritis",
        "MeSH ID": "D001172",
        "MeSH Term": "Arthritis, Rheumatoid",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "ALE-P02": null,
  "ALK-201": null,
  "ALK-202": null,
  "ALT-P7 (Neoaden\u24c7)": null,
  "AMB-302": null,
  "AMT-116": null,
  "AMT-151": null,
  "AMT-253": null,
  "AMT-562": null,
  "Anvatabart opadotin": {
    "Input Name": "Anvatabart opadotin",
    "Found": true,
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297892",
      "Preferred Name": "ANVATABART OPADOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "ARX-305": null,
  "ASCT2-ADC (HuB14-PL2202)": null,
  "ASN-004": {
    "Input Name": "ASN-004",
    "Found": true,
    "Primary Target Name": "Ephrin type-A receptor 3",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109398",
      "Preferred Name": "KB-004",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Ephrin type-A receptor 3 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL4954",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000198",
        "EFO Term": "myelodysplastic syndrome",
        "MeSH ID": "D009190",
        "MeSH Term": "Myelodysplastic Syndromes",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000519",
        "EFO Term": "glioblastoma multiforme",
        "MeSH ID": "D005909",
        "MeSH Term": "Glioblastoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0002430",
        "EFO Term": "primary myelofibrosis",
        "MeSH ID": "D055728",
        "MeSH Term": "Primary Myelofibrosis",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL4954",
        "Pref Name": "Ephrin type-A receptor 3",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P29320",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P29320",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "ATL-101": null,
  "ATN-022": {
    "Input Name": "ATN-022",
    "Found": true,
    "Primary Target Name": "Integrin alpha-5/beta-1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297456",
      "Preferred Name": "ATN-161",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Protein",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Integrin alpha-5/beta-1 antagonist",
        "Action Type": "ANTAGONIST",
        "Target ChEMBL ID": "CHEMBL2095226",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Integrin alpha-V/beta-3 antagonist",
        "Action Type": "ANTAGONIST",
        "Target ChEMBL ID": "CHEMBL1907598",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000681",
        "EFO Term": "renal cell carcinoma",
        "MeSH ID": "D002292",
        "MeSH Term": "Carcinoma, Renal Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000158",
        "EFO Term": "Central Nervous System Neoplasm",
        "MeSH ID": "D016543",
        "MeSH Term": "Central Nervous System Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1907598",
        "Pref Name": "Integrin alpha-V/beta-3",
        "Target Type": "PROTEIN COMPLEX",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P05106",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:1905598",
            "HGNC": "negative regulation of low-density lipoprotein receptor activity"
          },
          {
            "Accession": "P06756",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005886",
            "HGNC": "plasma membrane"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2095226",
        "Pref Name": "Integrin alpha-5/beta-1",
        "Target Type": "PROTEIN COMPLEX",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P05556",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P05556",
            "HGNC": null
          },
          {
            "Accession": "P08648",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P08648",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "AZD-0305": {
    "Input Name": "AZD-0305",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3894518",
      "Preferred Name": "AZD-8835",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "AZD-0901": {
    "Input Name": "AZD-0901",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3894518",
      "Preferred Name": "AZD-8835",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "AZD-5335": null,
  "AZD-9592": {
    "Input Name": "AZD-9592",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3894518",
      "Preferred Name": "AZD-8835",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "AZD-9829": {
    "Input Name": "AZD-9829",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3894518",
      "Preferred Name": "AZD-8835",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "B-006": null,
  "BA-1301": null,
  "BA-1302": null,
  "BAT_8010": null,
  "BAT-8006": {
    "Input Name": "BAT-8006",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL302424",
      "Preferred Name": "(TcN-BAT)nitridotechnetium complex of bis(aminoethanethiol)",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "BAT-8007": {
    "Input Name": "BAT-8007",
    "Found": true,
    "Primary Target Name": "Osteopontin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109530",
      "Preferred Name": "ASK-8007",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Osteopontin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1741309",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000685",
        "EFO Term": "rheumatoid arthritis",
        "MeSH ID": "D001172",
        "MeSH Term": "Arthritis, Rheumatoid",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1741309",
        "Pref Name": "Osteopontin",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P10451",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P10451",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "BAT-8008": {
    "Input Name": "BAT-8008",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL302424",
      "Preferred Name": "(TcN-BAT)nitridotechnetium complex of bis(aminoethanethiol)",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "BAT-8009": {
    "Input Name": "BAT-8009",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL302424",
      "Preferred Name": "(TcN-BAT)nitridotechnetium complex of bis(aminoethanethiol)",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "BB_1701": {
    "Input Name": "BB_1701",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314978",
      "Preferred Name": "BB-1701",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "BB-1701": {
    "Input Name": "BB-1701",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314978",
      "Preferred Name": "BB-1701",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "BB-1705": null,
  "BB-1709": null,
  "BCG019": null,
  "BCG022": null,
  "Belantamab mafodotin": {
    "Input Name": "Belantamab mafodotin",
    "Found": true,
    "Primary Target Name": "Tumor necrosis factor receptor superfamily member 17",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4298209",
      "Preferred Name": "BELANTAMAB MAFODOTIN",
      "Max Phase": "4.0",
      "First Approval": 2020,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor necrosis factor receptor superfamily member 17 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL4523587",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0019438",
        "EFO Term": "AL amyloidosis",
        "MeSH ID": "D028226",
        "MeSH Term": "Amyloidosis, Familial",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL4523587",
        "Pref Name": "Tumor necrosis factor receptor superfamily member 17",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q02223",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q02223",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Bezetabart debotansine": {
    "Input Name": "Bezetabart debotansine",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314812",
      "Preferred Name": "BEZETABART DEBOTANSINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "BioLink-018": null,
  "BL-M02D1": null,
  "BL-M05D1": null,
  "BL-M07D1": null,
  "BL-M11D1": null,
  "BL-M17D1": null,
  "Brentuximab vedotin": {
    "Input Name": "Brentuximab vedotin",
    "Found": true,
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1742994",
      "Preferred Name": "BRENTUXIMAB VEDOTIN",
      "Max Phase": "4.0",
      "First Approval": 2011,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tumor necrosis factor receptor superfamily member 8 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2364161",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000514",
        "EFO Term": "germ cell tumor",
        "MeSH ID": "D009373",
        "MeSH Term": "Neoplasms, Germ Cell and Embryonal",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000565",
        "EFO Term": "leukemia",
        "MeSH ID": "D007938",
        "MeSH Term": "Leukemia",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003032",
        "EFO Term": "anaplastic large cell lymphoma",
        "MeSH ID": "D017728",
        "MeSH Term": "Lymphoma, Large-Cell, Anaplastic",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:1001051",
        "EFO Term": "mycosis fungoides",
        "MeSH ID": "D009182",
        "MeSH Term": "Mycosis Fungoides",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000404",
        "EFO Term": "diffuse scleroderma",
        "MeSH ID": "D045743",
        "MeSH Term": "Scleroderma, Diffuse",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002913",
        "EFO Term": "Cutaneous T-cell lymphoma",
        "MeSH ID": "D016410",
        "MeSH Term": "Lymphoma, T-Cell, Cutaneous",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000785",
        "EFO Term": "Sezary's disease",
        "MeSH ID": "D012751",
        "MeSH Term": "Sezary Syndrome",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000211",
        "EFO Term": "unspecified peripheral T-cell lymphoma",
        "MeSH ID": "D016411",
        "MeSH Term": "Lymphoma, T-Cell, Peripheral",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000588",
        "EFO Term": "mesothelioma",
        "MeSH ID": "D008654",
        "MeSH Term": "Mesothelioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000095",
        "EFO Term": "chronic lymphocytic leukemia",
        "MeSH ID": "D015451",
        "MeSH Term": "Leukemia, Lymphocytic, Chronic, B-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000096",
        "EFO Term": "neoplasm of mature B-cells",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0007359",
        "EFO Term": "mast-cell leukemia",
        "MeSH ID": "D007946",
        "MeSH Term": "Leukemia, Mast-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0009348",
        "EFO Term": "classic Hodgkin lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0013730",
        "EFO Term": "graft versus host disease",
        "MeSH ID": "D006086",
        "MeSH Term": "Graft vs Host Disease",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0019471",
        "EFO Term": "adult T-cell leukemia/lymphoma",
        "MeSH ID": "D015459",
        "MeSH Term": "Leukemia-Lymphoma, Adult T-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0019473",
        "EFO Term": "enteropathy-associated T-cell lymphoma",
        "MeSH ID": "D058527",
        "MeSH Term": "Enteropathy-Associated T-Cell Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000764",
        "EFO Term": "HIV infection",
        "MeSH ID": "D015658",
        "MeSH Term": "HIV Infections",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0007915",
        "EFO Term": "systemic lupus erythematosus",
        "MeSH ID": "D008180",
        "MeSH Term": "Lupus Erythematosus, Systemic",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2364161",
        "Pref Name": "Tumor necrosis factor receptor superfamily member 8",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P28908",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P28908",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "BSI-992": null,
  "Bulumtatug fuvedotin": null,
  "Camidanlumab tesirine": {
    "Input Name": "Camidanlumab tesirine",
    "Found": true,
    "Primary Target Name": "Interleukin-2 receptor alpha chain",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297871",
      "Preferred Name": "CAMIDANLUMAB TESIRINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Interleukin-2 receptor alpha chain binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1778",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA cross-linking agent",
        "Action Type": "CROSS-LINKING AGENT",
        "Target ChEMBL ID": "CHEMBL2311221",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000220",
        "EFO Term": "acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000198",
        "EFO Term": "myelodysplastic syndrome",
        "MeSH ID": "D009190",
        "MeSH Term": "Myelodysplastic Syndromes",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0004251",
        "EFO Term": "myeloproliferative disorder",
        "MeSH ID": "D009196",
        "MeSH Term": "Myeloproliferative Disorders",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1778",
        "Pref Name": "Interleukin-2 receptor alpha chain",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P01589",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P01589",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2311221",
        "Pref Name": "DNA",
        "Target Type": "NUCLEIC-ACID",
        "Organism": "Homo sapiens",
        "Target Components": []
      }
    ]
  },
  "CBP-1018": null,
  "CM-518D1": null,
  "CMG901": null,
  "Cofetuzumab pelidotin (PF\u201106647020)": {
    "Input Name": "Cofetuzumab pelidotin (PF\u201106647020)",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3989983",
      "Preferred Name": "COFETUZUMAB PELIDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "CPO-301": null,
  "CRB-701": null,
  "CS-5001": null,
  "CS5007": null,
  "CUSP-06": null,
  "CX-2051": null,
  "DAC-002": null,
  "Datopotamab deruxtecan (Dato-DXd)": {
    "Input Name": "Datopotamab deruxtecan (Dato-DXd)",
    "Found": true,
    "Primary Target Name": "Tumor-associated calcium signal transducer 2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297939",
      "Preferred Name": "DATOPOTAMAB DERUXTECAN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor-associated calcium signal transducer 2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3856163",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008903",
        "EFO Term": "lung cancer",
        "MeSH ID": "D008175",
        "MeSH Term": "Lung Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3856163",
        "Pref Name": "Tumor-associated calcium signal transducer 2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P09758",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P09758",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "DB-1303 (BNT323)": null,
  "DB-1305": null,
  "DB-1310": null,
  "DB-1311": null,
  "DB-1312": null,
  "DB-1418": null,
  "DB-1419": null,
  "Disitamab vedotin": {
    "Input Name": "Disitamab vedotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095273",
      "Preferred Name": "DISITAMAB VEDOTIN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      }
    ],
    "Target Metadata": []
  },
  "DM-002": {
    "Input Name": "DM-002",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1078556",
      "Preferred Name": "PORICOIC ACID DM",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "Doxorubicin": {
    "Input Name": "Doxorubicin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL53463",
      "Preferred Name": "DOXORUBICIN",
      "Max Phase": "4.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-rubicin",
      "Indication Class": "Antineoplastic"
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004289",
        "EFO Term": "lymphoid leukemia",
        "MeSH ID": "D007945",
        "MeSH Term": "Leukemia, Lymphoid",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000691",
        "EFO Term": "sarcoma",
        "MeSH ID": "D012509",
        "MeSH Term": "Sarcoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0001075",
        "EFO Term": "ovarian carcinoma",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000313",
        "EFO Term": "carcinoma",
        "MeSH ID": "D002277",
        "MeSH Term": "Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000519",
        "EFO Term": "glioblastoma multiforme",
        "MeSH ID": "D005909",
        "MeSH Term": "Glioblastoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002913",
        "EFO Term": "Cutaneous T-cell lymphoma",
        "MeSH ID": "D016410",
        "MeSH Term": "Lymphoma, T-Cell, Cutaneous",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000220",
        "EFO Term": "acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004230",
        "EFO Term": "endometrial neoplasm",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001469",
        "EFO Term": "Mantle cell lymphoma",
        "MeSH ID": "D020522",
        "MeSH Term": "Lymphoma, Mantle-Cell",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000094",
        "EFO Term": "B-cell acute lymphoblastic leukemia",
        "MeSH ID": "D015456",
        "MeSH Term": "Leukemia, Biphenotypic, Acute",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000095",
        "EFO Term": "chronic lymphocytic leukemia",
        "MeSH ID": "D015451",
        "MeSH Term": "Leukemia, Lymphocytic, Chronic, B-Cell",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000096",
        "EFO Term": "neoplasm of mature B-cells",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000174",
        "EFO Term": "Ewing sarcoma",
        "MeSH ID": "D012512",
        "MeSH Term": "Sarcoma, Ewing",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000209",
        "EFO Term": "T-cell acute lymphoblastic leukemia",
        "MeSH ID": "D015456",
        "MeSH Term": "Leukemia, Biphenotypic, Acute",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000211",
        "EFO Term": "unspecified peripheral T-cell lymphoma",
        "MeSH ID": "D016411",
        "MeSH Term": "Lymphoma, T-Cell, Peripheral",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000231",
        "EFO Term": "adenoid cystic carcinoma",
        "MeSH ID": "D003528",
        "MeSH Term": "Carcinoma, Adenoid Cystic",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000255",
        "EFO Term": "angioimmunoblastic T-cell lymphoma",
        "MeSH ID": "D007119",
        "MeSH Term": "Immunoblastic Lymphadenopathy",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000309",
        "EFO Term": "Burkitts lymphoma",
        "MeSH ID": "D002051",
        "MeSH Term": "Burkitt Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000558",
        "EFO Term": "Kaposi's sarcoma",
        "MeSH ID": "D012514",
        "MeSH Term": "Sarcoma, Kaposi",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000564",
        "EFO Term": "leiomyosarcoma",
        "MeSH ID": "D007890",
        "MeSH Term": "Leiomyosarcoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000565",
        "EFO Term": "leukemia",
        "MeSH ID": "D007938",
        "MeSH Term": "Leukemia",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000588",
        "EFO Term": "mesothelioma",
        "MeSH ID": "D008654",
        "MeSH Term": "Mesothelioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000621",
        "EFO Term": "neuroblastoma",
        "MeSH ID": "D009447",
        "MeSH Term": "Neuroblastoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000630",
        "EFO Term": "oligoastrocytoma",
        "MeSH ID": "D009837",
        "MeSH Term": "Oligodendroglioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000632",
        "EFO Term": "oligodendroglioma",
        "MeSH ID": "D009837",
        "MeSH Term": "Oligodendroglioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000673",
        "EFO Term": "prostate adenocarcinoma",
        "MeSH ID": "D011471",
        "MeSH Term": "Prostatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000681",
        "EFO Term": "renal cell carcinoma",
        "MeSH ID": "D002292",
        "MeSH Term": "Carcinoma, Renal Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000770",
        "EFO Term": "malignant pleural mesothelioma",
        "MeSH ID": "D008654",
        "MeSH Term": "Mesothelioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0002499",
        "EFO Term": "anaplastic astrocytoma",
        "MeSH ID": "D001254",
        "MeSH Term": "Astrocytoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002618",
        "EFO Term": "pancreatic carcinoma",
        "MeSH ID": "D010190",
        "MeSH Term": "Pancreatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002918",
        "EFO Term": "rhabdomyosarcoma",
        "MeSH ID": "D012208",
        "MeSH Term": "Rhabdomyosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003032",
        "EFO Term": "anaplastic large cell lymphoma",
        "MeSH ID": "D017728",
        "MeSH Term": "Lymphoma, Large-Cell, Anaplastic",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004252",
        "EFO Term": "nasopharyngeal neoplasm",
        "MeSH ID": "D009303",
        "MeSH Term": "Nasopharyngeal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005221",
        "EFO Term": "cholangiocarcinoma",
        "MeSH ID": "D018281",
        "MeSH Term": "Cholangiocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0006475",
        "EFO Term": "plasma cell leukemia",
        "MeSH ID": "D007952",
        "MeSH Term": "Leukemia, Plasma Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006861",
        "EFO Term": "male breast carcinoma",
        "MeSH ID": "D018567",
        "MeSH Term": "Breast Neoplasms, Male",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001365",
        "EFO Term": "Lymphoma, AIDS-Related",
        "MeSH ID": "D016483",
        "MeSH Term": "Lymphoma, AIDS-Related",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001968",
        "EFO Term": "soft tissue sarcoma",
        "MeSH ID": "D012509",
        "MeSH Term": "Sarcoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "Orphanet:145",
        "EFO Term": "Hereditary breast and ovarian cancer syndrome",
        "MeSH ID": "D061325",
        "MeSH Term": "Hereditary Breast and Ovarian Cancer Syndrome",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000198",
        "EFO Term": "myelodysplastic syndrome",
        "MeSH ID": "D009190",
        "MeSH Term": "Myelodysplastic Syndromes",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0009254",
        "EFO Term": "optic nerve glioblastoma",
        "MeSH ID": "D020339",
        "MeSH Term": "Optic Nerve Glioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000251",
        "EFO Term": "Fallopian Tube Carcinoma",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1000576",
        "EFO Term": "Thymic Carcinoma",
        "MeSH ID": "D013945",
        "MeSH Term": "Thymoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000581",
        "EFO Term": "Thymoma",
        "MeSH ID": "D013945",
        "MeSH Term": "Thymoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001100",
        "EFO Term": "peritoneal neoplasm",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "HP:0002017",
        "EFO Term": "Nausea and vomiting",
        "MeSH ID": "D020250",
        "MeSH Term": "Postoperative Nausea and Vomiting",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000432",
        "EFO Term": "breast ductal carcinoma in situ",
        "MeSH ID": "D002285",
        "MeSH Term": "Carcinoma, Intraductal, Noninfiltrating",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000502",
        "EFO Term": "ganglioneuroblastoma",
        "MeSH ID": "D018305",
        "MeSH Term": "Ganglioneuroblastoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000131",
        "EFO Term": "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
        "MeSH ID": "D001752",
        "MeSH Term": "Blast Crisis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000292",
        "EFO Term": "Hepatoblastoma",
        "MeSH ID": "D018197",
        "MeSH Term": "Hepatoblastoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001901",
        "EFO Term": "neuroendocrine neoplasm",
        "MeSH ID": "D018358",
        "MeSH Term": "Neuroendocrine Tumors",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "HP:0001871",
        "EFO Term": "Abnormality of blood and blood-forming tissues",
        "MeSH ID": "D006402",
        "MeSH Term": "Hematologic Diseases",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0000870",
        "EFO Term": "childhood acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0000873",
        "EFO Term": "lymphoblastic lymphoma",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001475",
        "EFO Term": "neutropenia",
        "MeSH ID": "D009503",
        "MeSH Term": "Neutropenia",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001657",
        "EFO Term": "brain cancer",
        "MeSH ID": "D001932",
        "MeSH Term": "Brain Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0002087",
        "EFO Term": "peritoneum cancer",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0002108",
        "EFO Term": "thyroid cancer",
        "MeSH ID": "D013964",
        "MeSH Term": "Thyroid Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0002691",
        "EFO Term": "liver cancer",
        "MeSH ID": "D008113",
        "MeSH Term": "Liver Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0002928",
        "EFO Term": "carcinosarcoma",
        "MeSH ID": "D002296",
        "MeSH Term": "Carcinosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004095",
        "EFO Term": "B-cell neoplasm",
        "MeSH ID": "D016393",
        "MeSH Term": "Lymphoma, B-Cell",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004192",
        "EFO Term": "urethra cancer",
        "MeSH ID": "D014523",
        "MeSH Term": "Urethral Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004658",
        "EFO Term": "breast carcinoma in situ",
        "MeSH ID": "D000071960",
        "MeSH Term": "Breast Carcinoma In Situ",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0009348",
        "EFO Term": "classic Hodgkin lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0015540",
        "EFO Term": "hemophagocytic syndrome",
        "MeSH ID": "D051359",
        "MeSH Term": "Lymphohistiocytosis, Hemophagocytic",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0015564",
        "EFO Term": "Castleman disease",
        "MeSH ID": "D005871",
        "MeSH Term": "Castleman Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0015760",
        "EFO Term": "T-cell non-Hodgkin lymphoma",
        "MeSH ID": "D016399",
        "MeSH Term": "Lymphoma, T-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0016691",
        "EFO Term": "pilocytic astrocytoma",
        "MeSH ID": "D001254",
        "MeSH Term": "Astrocytoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0016717",
        "EFO Term": "choroid plexus neoplasm",
        "MeSH ID": "D016545",
        "MeSH Term": "Choroid Plexus Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0018531",
        "EFO Term": "carcinoma of liver and intrahepatic biliary tract",
        "MeSH ID": "D008113",
        "MeSH Term": "Liver Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0019004",
        "EFO Term": "kidney Wilms tumor",
        "MeSH ID": "D009396",
        "MeSH Term": "Wilms Tumor",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0019460",
        "EFO Term": "acute leukemia of ambiguous lineage",
        "MeSH ID": "D015456",
        "MeSH Term": "Leukemia, Biphenotypic, Acute",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0019471",
        "EFO Term": "adult T-cell leukemia/lymphoma",
        "MeSH ID": "D015459",
        "MeSH Term": "Leukemia-Lymphoma, Adult T-Cell",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0019472",
        "EFO Term": "extranodal nasal NK/T cell lymphoma",
        "MeSH ID": "D006103",
        "MeSH Term": "Granuloma, Lethal Midline",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000389",
        "EFO Term": "cutaneous melanoma",
        "MeSH ID": "D008545",
        "MeSH Term": "Melanoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0002617",
        "EFO Term": "metastatic melanoma",
        "MeSH ID": "D008545",
        "MeSH Term": "Melanoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0100342",
        "EFO Term": "malignant glioma",
        "MeSH ID": "D005910",
        "MeSH Term": "Glioma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002517",
        "EFO Term": "pancreatic ductal adenocarcinoma",
        "MeSH ID": "D021441",
        "MeSH Term": "Carcinoma, Pancreatic Ductal",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000350",
        "EFO Term": "Malignant Bone Neoplasm",
        "MeSH ID": "D001859",
        "MeSH Term": "Bone Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0000432",
        "EFO Term": "lymphoplasmacytic lymphoma",
        "MeSH ID": "D008258",
        "MeSH Term": "Waldenstrom Macroglobulinemia",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0002367",
        "EFO Term": "kidney cancer",
        "MeSH ID": "D007680",
        "MeSH Term": "Kidney Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0002730",
        "EFO Term": "childhood kidney neoplasm",
        "MeSH ID": "D007680",
        "MeSH Term": "Kidney Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0021117",
        "EFO Term": "lung neoplasm",
        "MeSH ID": "D008175",
        "MeSH Term": "Lung Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003085",
        "EFO Term": "dedifferentiated liposarcoma",
        "MeSH ID": "D008080",
        "MeSH Term": "Liposarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003868",
        "EFO Term": "mouth neoplasm",
        "MeSH ID": "D009062",
        "MeSH Term": "Mouth Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0000430",
        "EFO Term": "mature T-cell and NK-cell non-Hodgkin lymphoma",
        "MeSH ID": "D016411",
        "MeSH Term": "Lymphoma, T-Cell, Peripheral",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008380",
        "EFO Term": "retinoblastoma",
        "MeSH ID": "D012175",
        "MeSH Term": "Retinoblastoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0017816",
        "EFO Term": "primary systemic amyloidosis",
        "MeSH ID": "D000075363",
        "MeSH Term": "Immunoglobulin Light-chain Amyloidosis",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0018364",
        "EFO Term": "malignant epithelial tumor of ovary",
        "MeSH ID": "D000077216",
        "MeSH Term": "Carcinoma, Ovarian Epithelial",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0044881",
        "EFO Term": "hematopoietic and lymphoid cell neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003833",
        "EFO Term": "brain neoplasm",
        "MeSH ID": "D001932",
        "MeSH Term": "Brain Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0009907",
        "EFO Term": "Desmoid-type fibromatosis",
        "MeSH ID": "D018222",
        "MeSH Term": "Fibromatosis, Aggressive",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1000796",
        "EFO Term": "adrenal cortex carcinoma",
        "MeSH ID": "D000306",
        "MeSH Term": "Adrenal Cortex Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0044917",
        "EFO Term": "T-lymphoblastic lymphoma",
        "MeSH ID": "D054218",
        "MeSH Term": "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "3.0"
      }
    ],
    "Target Metadata": []
  },
  "DP-303c": null,
  "DS-3939": null,
  "DS-9606": {
    "Input Name": "DS-9606",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1631759",
      "Preferred Name": "JADOMYCIN DS",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "DX126-262": null,
  "DXC-005": null,
  "DXC-006": null,
  "DXC-007": null,
  "DXC-1002": null,
  "DXC018": null,
  "EBC\u2011129": null,
  "Emiltatug ledadotin": null,
  "Enfortumab vedotin": {
    "Input Name": "Enfortumab vedotin",
    "Found": true,
    "Primary Target Name": "Nectin-4",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3301589",
      "Preferred Name": "ENFORTUMAB VEDOTIN",
      "Max Phase": "4.0",
      "First Approval": 2019,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Nectin-4 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712928",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002517",
        "EFO Term": "pancreatic ductal adenocarcinoma",
        "MeSH ID": "D021441",
        "MeSH Term": "Carcinoma, Pancreatic Ductal",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000601",
        "EFO Term": "Transitional Cell Carcinoma",
        "MeSH ID": "D002295",
        "MeSH Term": "Carcinoma, Transitional Cell",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004180",
        "EFO Term": "benign urinary system neoplasm",
        "MeSH ID": "D014571",
        "MeSH Term": "Urologic Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3712928",
        "Pref Name": "Nectin-4",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q96NY8",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q96NY8",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "EO-3021": null,
  "Epratuzumab tesirine": {
    "Input Name": "Epratuzumab tesirine",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297872",
      "Preferred Name": "EPRATUZUMAB-CYS-TESIRINE",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000220",
        "EFO Term": "acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "ESG-401": null,
  "Etx-22": null,
  "F0002-ADC": null,
  "Farletuzumab ecteribulin": {
    "Input Name": "Farletuzumab ecteribulin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4802212",
      "Preferred Name": "FARLETUZUMAB ECTERIBULIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-bulin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "FDA-018": null,
  "FDA-022": {
    "Input Name": "FDA-022",
    "Found": true,
    "Primary Target Name": "Insulin-like growth factor I receptor",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109356",
      "Preferred Name": "BIIB-022",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Insulin-like growth factor I receptor inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1957",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1957",
        "Pref Name": "Insulin-like growth factor I receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P08069",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0038083",
            "HGNC": "peptidyl-tyrosine autophosphorylation"
          }
        ]
      }
    ]
  },
  "FG-3246": null,
  "FGFR2b ADC": null,
  "FZ-AD004": {
    "Input Name": "FZ-AD004",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL558",
      "Preferred Name": "MEXILETINE",
      "Max Phase": "4.0",
      "First Approval": 1985,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": "Cardiac Depressant (anti-arrhythmic)"
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000555",
        "EFO Term": "irritable bowel syndrome",
        "MeSH ID": "D043183",
        "MeSH Term": "Irritable Bowel Syndrome",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0004269",
        "EFO Term": "cardiac arrhythmia",
        "MeSH ID": "D001145",
        "MeSH Term": "Arrhythmias, Cardiac",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000612",
        "EFO Term": "myocardial infarction",
        "MeSH ID": "D009203",
        "MeSH Term": "Myocardial Infarction",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004278",
        "EFO Term": "sudden cardiac arrest",
        "MeSH ID": "D016757",
        "MeSH Term": "Death, Sudden, Cardiac",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004287",
        "EFO Term": "ventricular fibrillation",
        "MeSH ID": "D014693",
        "MeSH Term": "Ventricular Fibrillation",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "HP:0012532",
        "EFO Term": "Chronic pain",
        "MeSH ID": "D059350",
        "MeSH Term": "Chronic Pain",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "Orphanet:273",
        "EFO Term": "Steinert myotonic dystrophy",
        "MeSH ID": "D009223",
        "MeSH Term": "Myotonic Dystrophy",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0015626",
        "EFO Term": "Charcot-Marie-Tooth disease",
        "MeSH ID": "D002607",
        "MeSH Term": "Charcot-Marie-Tooth Disease",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0016107",
        "EFO Term": "myotonic dystrophy",
        "MeSH ID": "D009223",
        "MeSH Term": "Myotonic Dystrophy",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0011728",
        "EFO Term": "blepharospasm",
        "MeSH ID": "D001764",
        "MeSH Term": "Blepharospasm",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "FZ-AD005": {
    "Input Name": "FZ-AD005",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL558",
      "Preferred Name": "MEXILETINE",
      "Max Phase": "4.0",
      "First Approval": 1985,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": "Cardiac Depressant (anti-arrhythmic)"
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000555",
        "EFO Term": "irritable bowel syndrome",
        "MeSH ID": "D043183",
        "MeSH Term": "Irritable Bowel Syndrome",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0004269",
        "EFO Term": "cardiac arrhythmia",
        "MeSH ID": "D001145",
        "MeSH Term": "Arrhythmias, Cardiac",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000612",
        "EFO Term": "myocardial infarction",
        "MeSH ID": "D009203",
        "MeSH Term": "Myocardial Infarction",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004278",
        "EFO Term": "sudden cardiac arrest",
        "MeSH ID": "D016757",
        "MeSH Term": "Death, Sudden, Cardiac",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004287",
        "EFO Term": "ventricular fibrillation",
        "MeSH ID": "D014693",
        "MeSH Term": "Ventricular Fibrillation",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "HP:0012532",
        "EFO Term": "Chronic pain",
        "MeSH ID": "D059350",
        "MeSH Term": "Chronic Pain",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "Orphanet:273",
        "EFO Term": "Steinert myotonic dystrophy",
        "MeSH ID": "D009223",
        "MeSH Term": "Myotonic Dystrophy",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0015626",
        "EFO Term": "Charcot-Marie-Tooth disease",
        "MeSH ID": "D002607",
        "MeSH Term": "Charcot-Marie-Tooth Disease",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0016107",
        "EFO Term": "myotonic dystrophy",
        "MeSH ID": "D009223",
        "MeSH Term": "Myotonic Dystrophy",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0011728",
        "EFO Term": "blepharospasm",
        "MeSH ID": "D001764",
        "MeSH Term": "Blepharospasm",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Glembatumumab vedotin (CDX-011)": {
    "Input Name": "Glembatumumab vedotin (CDX-011)",
    "Found": true,
    "Primary Target Name": "Transmembrane glycoprotein NMB",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1743028",
      "Preferred Name": "GLEMBATUMUMAB VEDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Transmembrane glycoprotein NMB binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712919",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000708",
        "EFO Term": "squamous cell lung carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000756",
        "EFO Term": "melanoma",
        "MeSH ID": "D008545",
        "MeSH Term": "Melanoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3712919",
        "Pref Name": "Transmembrane glycoprotein NMB",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q14956",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q14956",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      }
    ]
  },
  "HDP-101 (Patisiran vedotin)": {
    "Input Name": "HDP-101 (Patisiran vedotin)",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3989987",
      "Preferred Name": "PATISIRAN",
      "Max Phase": "4.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Oligonucleotide",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Transthyretin mRNA RNAi inhibitor",
        "Action Type": "RNAI INHIBITOR",
        "Target ChEMBL ID": "CHEMBL4296221",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:1001875",
        "EFO Term": "amyloidosis",
        "MeSH ID": "D000686",
        "MeSH Term": "Amyloidosis",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0004129",
        "EFO Term": "familial amyloid neuropathy",
        "MeSH ID": "D028227",
        "MeSH Term": "Amyloid Neuropathies, Familial",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1000783",
        "EFO Term": "diabetic neuropathy",
        "MeSH ID": "D003929",
        "MeSH Term": "Diabetic Neuropathies",
        "Max Phase for Indication": "0.5"
      }
    ],
    "Target Metadata": []
  },
  "HDP-102": null,
  "HDP-103": null,
  "HuB14\u2011VA\u2011PL2202": null,
  "IBI-354": {
    "Input Name": "IBI-354",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594553",
      "Preferred Name": "IBI-188",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000198",
        "EFO Term": "myelodysplastic syndrome",
        "MeSH ID": "D009190",
        "MeSH Term": "Myelodysplastic Syndromes",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "IBI3026": null,
  "ICON-2": {
    "Input Name": "ICON-2",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL299613",
      "Preferred Name": "2-METHOXYESTRADIOL",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-estr-",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Ifinatamab deruxtecan": {
    "Input Name": "Ifinatamab deruxtecan",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095331",
      "Preferred Name": "IFINATAMAB DERUXTECAN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "IKS014 (FS-1502)": null,
  "IKS03": null,
  "IKS04\u2011(CA242 ADC)": null,
  "IM-1021": null,
  "IMD2113": null,
  "IMGN-151": {
    "Input Name": "IMGN-151",
    "Found": true,
    "Primary Target Name": "Vitronectin receptor alpha",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109633",
      "Preferred Name": "IMGN-388",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Vitronectin receptor alpha binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3660",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3660",
        "Pref Name": "Vitronectin receptor alpha",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P06756",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P06756",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "INA-03": {
    "Input Name": "INA-03",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314916",
      "Preferred Name": "ENT-03",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "Indatuximab ravtansine": {
    "Input Name": "Indatuximab ravtansine",
    "Found": true,
    "Primary Target Name": "Syndecan-1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1743031",
      "Preferred Name": "INDATUXIMAB RAVTANSINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Syndecan-1 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712898",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3712898",
        "Pref Name": "Syndecan-1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P18827",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P18827",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Indusatumab vedotin (MLN\u20110264 / TAK\u2011264)": {
    "Input Name": "Indusatumab vedotin (MLN\u20110264 / TAK\u2011264)",
    "Found": true,
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4298045",
      "Preferred Name": "INDUSATUMAB VEDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Heat-stable enterotoxin receptor binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1795197",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1795197",
        "Pref Name": "Heat-stable enterotoxin receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P25092",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P25092",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Inotuzumab ozogamicin": {
    "Input Name": "Inotuzumab ozogamicin",
    "Found": true,
    "Primary Target Name": "CD22",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2108611",
      "Preferred Name": "INOTUZUMAB OZOGAMICIN",
      "Max Phase": "4.0",
      "First Approval": 2017,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -micin",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "CD22 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3218",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000220",
        "EFO Term": "acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000094",
        "EFO Term": "B-cell acute lymphoblastic leukemia",
        "MeSH ID": "D015452",
        "MeSH Term": "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000096",
        "EFO Term": "neoplasm of mature B-cells",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000094",
        "EFO Term": "B-cell acute lymphoblastic leukemia",
        "MeSH ID": "D015456",
        "MeSH Term": "Leukemia, Biphenotypic, Acute",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000131",
        "EFO Term": "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
        "MeSH ID": "D001752",
        "MeSH Term": "Blast Crisis",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0000873",
        "EFO Term": "lymphoblastic lymphoma",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0044881",
        "EFO Term": "hematopoietic and lymphoid cell neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000309",
        "EFO Term": "Burkitts lymphoma",
        "MeSH ID": "D002051",
        "MeSH Term": "Burkitt Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000565",
        "EFO Term": "leukemia",
        "MeSH ID": "D007938",
        "MeSH Term": "Leukemia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004289",
        "EFO Term": "lymphoid leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3218",
        "Pref Name": "CD22",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P20273",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P20273",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "IPH-4502": {
    "Input Name": "IPH-4502",
    "Found": true,
    "Primary Target Name": "Killer cell immunoglobulin-like receptor 2DL2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109498",
      "Preferred Name": "IPH-2101",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Killer cell immunoglobulin-like receptor 2DL2 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3833441",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Killer cell immunoglobulin-like receptor 2DL3 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3713026",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Killer cell immunoglobulin-like receptor 2DL1 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3712912",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3833441",
        "Pref Name": "Killer cell immunoglobulin-like receptor 2DL2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P43627",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P43627",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3713026",
        "Pref Name": "Killer cell immunoglobulin-like receptor 2DL3",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P43628",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P43628",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3712912",
        "Pref Name": "Killer cell immunoglobulin-like receptor 2DL1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P43626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P43626",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Izalontamab brengitecan": {
    "Input Name": "Izalontamab brengitecan",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314841",
      "Preferred Name": "IZALONTAMAB BRENGITECAN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Izeltabart tapatansine": {
    "Input Name": "Izeltabart tapatansine",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095346",
      "Preferred Name": "IZELTABART TAPATANSINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "JBH-492": null,
  "JNJ-8177": {
    "Input Name": "JNJ-8177",
    "Found": true,
    "Primary Target Name": "Anandamide amidohydrolase",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297294",
      "Preferred Name": "JNJ-42165279",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Anandamide amidohydrolase inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2243",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003756",
        "EFO Term": "autism spectrum disorder",
        "MeSH ID": "D002659",
        "MeSH Term": "Child Development Disorders, Pervasive",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001908",
        "EFO Term": "phobic disorder",
        "MeSH ID": "D010698",
        "MeSH Term": "Phobic Disorders",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2243",
        "Pref Name": "Anandamide amidohydrolase",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "O00519",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "O00519",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "JS-107": null,
  "JSKN-003": null,
  "JSKN-016": null,
  "JSKN-033": null,
  "JSKN021": null,
  "KH815": null,
  "KK-2845": null,
  "KM-501": null,
  "KS1/4-vinblastine": null,
  "KY-0301": null,
  "L-DOS-47": null,
  "LCB-14": null,
  "LCB-84": null,
  "LM-302": null,
  "LNCB-74": null,
  "Loncastuximab tesirine": {
    "Input Name": "Loncastuximab tesirine",
    "Found": true,
    "Primary Target Name": "B-lymphocyte antigen CD19",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297778",
      "Preferred Name": "LONCASTUXIMAB TESIRINE",
      "Max Phase": "4.0",
      "First Approval": 2021,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "B-lymphocyte antigen CD19 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3390821",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA cross-linking agent",
        "Action Type": "CROSS-LINKING AGENT",
        "Target ChEMBL ID": "CHEMBL2311221",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000220",
        "EFO Term": "acute lymphoblastic leukemia",
        "MeSH ID": "D054198",
        "MeSH Term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:1001938",
        "EFO Term": "B-cell non-Hodgkins lymphoma",
        "MeSH ID": "D016393",
        "MeSH Term": "Lymphoma, B-Cell",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000096",
        "EFO Term": "neoplasm of mature B-cells",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000309",
        "EFO Term": "Burkitts lymphoma",
        "MeSH ID": "D002051",
        "MeSH Term": "Burkitt Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009441",
        "EFO Term": "Waldenstrom macroglobulinemia",
        "MeSH ID": "D008258",
        "MeSH Term": "Waldenstrom Macroglobulinemia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001469",
        "EFO Term": "Mantle cell lymphoma",
        "MeSH ID": "D020522",
        "MeSH Term": "Lymphoma, Mantle-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3390821",
        "Pref Name": "B-lymphocyte antigen CD19",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P15391",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P15391",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2311221",
        "Pref Name": "DNA",
        "Target Type": "NUCLEIC-ACID",
        "Organism": "Homo sapiens",
        "Target Components": []
      }
    ]
  },
  "Lonigutamab ugodotin": {
    "Input Name": "Lonigutamab ugodotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314990",
      "Preferred Name": "LONIGUTAMAB",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:1001466",
        "EFO Term": "Graves ophthalmopathy",
        "MeSH ID": "D049970",
        "MeSH Term": "Graves Ophthalmopathy",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "LY-4052031": null,
  "M-3554": null,
  "M-9140": {
    "Input Name": "M-9140",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL451147",
      "Preferred Name": "RENIERAMYCIN M",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "MBK-103": null,
  "MBRC-101": null,
  "Mecbotamab vedotin": {
    "Input Name": "Mecbotamab vedotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095312",
      "Preferred Name": "MECBOTAMAB VEDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "MGC-026": null,
  "MGC-028": {
    "Input Name": "MGC-028",
    "Found": true,
    "Primary Target Name": "Tyrosine-protein kinase receptor FLT3",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4790100",
      "Preferred Name": "AKN-028",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tyrosine-protein kinase receptor FLT3 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1974",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1974",
        "Pref Name": "Tyrosine-protein kinase receptor FLT3",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P36888",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P36888",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "MHB-036C": null,
  "MHB-088C": null,
  "Micvotabart pelidotin (MICVO) (PYX-201)": {
    "Input Name": "Micvotabart pelidotin (MICVO) (PYX-201)",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3989983",
      "Preferred Name": "COFETUZUMAB PELIDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "Mirvetuximab soravtansine (Elhare)": {
    "Input Name": "Mirvetuximab soravtansine (Elhare)",
    "Found": true,
    "Primary Target Name": "Folate receptor alpha",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3545132",
      "Preferred Name": "MIRVETUXIMAB SORAVTANSINE",
      "Max Phase": "4.0",
      "First Approval": 2022,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Folate receptor alpha binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL2121",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001100",
        "EFO Term": "peritoneal neoplasm",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0018364",
        "EFO Term": "malignant epithelial tumor of ovary",
        "MeSH ID": "D000077216",
        "MeSH Term": "Carcinoma, Ovarian Epithelial",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0021092",
        "EFO Term": "fallopian tube neoplasm",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2121",
        "Pref Name": "Folate receptor alpha",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P15328",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P15328",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "MRG-001": null,
  "MRG-003 (Becotatug vedotin)": {
    "Input Name": "MRG-003 (Becotatug vedotin)",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5315031",
      "Preferred Name": "MRG-003",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000181",
        "EFO Term": "head and neck squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004252",
        "EFO Term": "nasopharyngeal neoplasm",
        "MeSH ID": "D009303",
        "MeSH Term": "Nasopharyngeal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0003060",
        "EFO Term": "biliary tract cancer",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "MRG-004": {
    "Input Name": "MRG-004",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5315031",
      "Preferred Name": "MRG-003",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000181",
        "EFO Term": "head and neck squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004252",
        "EFO Term": "nasopharyngeal neoplasm",
        "MeSH ID": "D009303",
        "MeSH Term": "Nasopharyngeal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0003060",
        "EFO Term": "biliary tract cancer",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "MRG-006": null,
  "MTX-13": null,
  "MYTX-011": null,
  "Nab-paclitaxel, ADNAB": null,
  "Naratuximab emtansine": {
    "Input Name": "Naratuximab emtansine",
    "Found": true,
    "Primary Target Name": "Leukocyte antigen CD37",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109268",
      "Preferred Name": "NARATUXIMAB EMTANSINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Leukocyte antigen CD37 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712880",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000095",
        "EFO Term": "chronic lymphocytic leukemia",
        "MeSH ID": "D015451",
        "MeSH Term": "Leukemia, Lymphocytic, Chronic, B-Cell",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3712880",
        "Pref Name": "Leukocyte antigen CD37",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11049",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11049",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "NBT-508": null,
  "NC-18": null,
  "NI-2201": null,
  "NN-3201": null,
  "Oberotatug ravtansine": {
    "Input Name": "Oberotatug ravtansine",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314757",
      "Preferred Name": "OBEROTATUG RAVTANSINE",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "OMTX-705": null,
  "OQY-6129": null,
  "ORM-6151": {
    "Input Name": "ORM-6151",
    "Found": true,
    "Primary Target Name": "Alpha-2c adrenergic receptor",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297312",
      "Preferred Name": "ORM-12741",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Alpha-2c adrenergic receptor antagonist",
        "Action Type": "ANTAGONIST",
        "Target ChEMBL ID": "CHEMBL1916",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0004975",
        "EFO Term": "Alzheimer disease",
        "MeSH ID": "D000544",
        "MeSH Term": "Alzheimer Disease",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1916",
        "Pref Name": "Alpha-2c adrenergic receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P18825",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P18825",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Ozuriftamab vedotin": {
    "Input Name": "Ozuriftamab vedotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095285",
      "Preferred Name": "OZURIFTAMAB VEDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Patritumab deruxtecan": {
    "Input Name": "Patritumab deruxtecan",
    "Found": true,
    "Primary Target Name": "Receptor tyrosine-protein kinase erbB-3",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594611",
      "Preferred Name": "PATRITUMAB DERUXTECAN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor tyrosine-protein kinase erbB-3 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL5838",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL5838",
        "Pref Name": "Receptor tyrosine-protein kinase erbB-3",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P21860",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P21860",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Patritumab deruxtecan*": {
    "Input Name": "Patritumab deruxtecan*",
    "Found": true,
    "Primary Target Name": "Receptor tyrosine-protein kinase erbB-3",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594611",
      "Preferred Name": "PATRITUMAB DERUXTECAN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor tyrosine-protein kinase erbB-3 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL5838",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL5838",
        "Pref Name": "Receptor tyrosine-protein kinase erbB-3",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P21860",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P21860",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Pivekimab sunirine": {
    "Input Name": "Pivekimab sunirine",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297991",
      "Preferred Name": "PIVEKIMAB SUNIRINE",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "Pivekimab sunirine (IMGN-632)": {
    "Input Name": "Pivekimab sunirine (IMGN-632)",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297991",
      "Preferred Name": "PIVEKIMAB SUNIRINE",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "Polatuzumab vedotin": {
    "Input Name": "Polatuzumab vedotin",
    "Found": true,
    "Primary Target Name": "B-cell antigen receptor complex-associated protein beta chain",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3301582",
      "Preferred Name": "POLATUZUMAB VEDOTIN",
      "Max Phase": "4.0",
      "First Approval": 2019,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "B-cell antigen receptor complex-associated protein beta chain binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3712852",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000095",
        "EFO Term": "chronic lymphocytic leukemia",
        "MeSH ID": "D015451",
        "MeSH Term": "Leukemia, Lymphocytic, Chronic, B-Cell",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000096",
        "EFO Term": "neoplasm of mature B-cells",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:1001469",
        "EFO Term": "Mantle cell lymphoma",
        "MeSH ID": "D020522",
        "MeSH Term": "Lymphoma, Mantle-Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004095",
        "EFO Term": "B-cell neoplasm",
        "MeSH ID": "D016393",
        "MeSH Term": "Lymphoma, B-Cell",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL3712852",
        "Pref Name": "B-cell antigen receptor complex-associated protein beta chain",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P40259",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P40259",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "PRO1107": null,
  "PRO1160": null,
  "PRO1286": null,
  "Puxitatug samrotecan": {
    "Input Name": "Puxitatug samrotecan",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314766",
      "Preferred Name": "PUXITATUG SAMROTECAN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Raludotatug deruxtecan": {
    "Input Name": "Raludotatug deruxtecan",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5095329",
      "Preferred Name": "RALUDOTATUG DERUXTECAN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "RC-108": {
    "Input Name": "RC-108",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL451702",
      "Preferred Name": "GINSENOSIDE RC",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "RC-118": {
    "Input Name": "RC-118",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL451702",
      "Preferred Name": "GINSENOSIDE RC",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "RC-88": {
    "Input Name": "RC-88",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL451702",
      "Preferred Name": "GINSENOSIDE RC",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "RC-48": {
    "Input Name": "RC-48",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL451702",
      "Preferred Name": "GINSENOSIDE RC",
      "Max Phase": null,
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "Rinatabart sesutecan": null,
  "Rinatabart Sesutecan (Rina\u2011S)\u00a0": {
    "Input Name": "Rinatabart Sesutecan (Rina\u2011S)\u00a0",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL297792",
      "Preferred Name": "S-3304",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "RVU305": null,
  "S-227928": {
    "Input Name": "S-227928",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL297792",
      "Preferred Name": "S-3304",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "Sacituzumab govitecan (Trodelvy)": {
    "Input Name": "Sacituzumab govitecan (Trodelvy)",
    "Found": true,
    "Primary Target Name": "Tumor-associated calcium signal transducer 2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3545262",
      "Preferred Name": "SACITUZUMAB GOVITECAN",
      "Max Phase": "4.0",
      "First Approval": 2020,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor-associated calcium signal transducer 2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3856163",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000519",
        "EFO Term": "glioblastoma multiforme",
        "MeSH ID": "D005909",
        "MeSH Term": "Glioblastoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001512",
        "EFO Term": "endometrial carcinoma",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3856163",
        "Pref Name": "Tumor-associated calcium signal transducer 2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P09758",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P09758",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Sacituzumab tetbirotan (SKB-264)": {
    "Input Name": "Sacituzumab tetbirotan (SKB-264)",
    "Found": true,
    "Primary Target Name": "Tumor-associated calcium signal transducer 2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3545262",
      "Preferred Name": "SACITUZUMAB GOVITECAN",
      "Max Phase": "4.0",
      "First Approval": 2020,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor-associated calcium signal transducer 2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3856163",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000519",
        "EFO Term": "glioblastoma multiforme",
        "MeSH ID": "D005909",
        "MeSH Term": "Glioblastoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001512",
        "EFO Term": "endometrial carcinoma",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3856163",
        "Pref Name": "Tumor-associated calcium signal transducer 2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P09758",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P09758",
            "HGNC": null
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Sacituzumab tirumotecan": {
    "Input Name": "Sacituzumab tirumotecan",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314875",
      "Preferred Name": "SACITUZUMAB TIRUMOTECAN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "SAR-445953": {
    "Input Name": "SAR-445953",
    "Found": true,
    "Primary Target Name": "Mucin-1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109635",
      "Preferred Name": "SAR-566658",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Mucin-1 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL3580494",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3580494",
        "Pref Name": "Mucin-1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P15941",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P15941",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SG-2918": null,
  "SGN-35C": {
    "Input Name": "SGN-35C",
    "Found": true,
    "Primary Target Name": "Tumor necrosis factor receptor superfamily member 8",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109256",
      "Preferred Name": "SGN-30",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor necrosis factor receptor superfamily member 8 agonist",
        "Action Type": "AGONIST",
        "Target ChEMBL ID": "CHEMBL2364161",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000558",
        "EFO Term": "Kaposi's sarcoma",
        "MeSH ID": "D012514",
        "MeSH Term": "Sarcoma, Kaposi",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002913",
        "EFO Term": "Cutaneous T-cell lymphoma",
        "MeSH ID": "D016410",
        "MeSH Term": "Lymphoma, T-Cell, Cutaneous",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003032",
        "EFO Term": "anaplastic large cell lymphoma",
        "MeSH ID": "D017728",
        "MeSH Term": "Lymphoma, Large-Cell, Anaplastic",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2364161",
        "Pref Name": "Tumor necrosis factor receptor superfamily member 8",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P28908",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P28908",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SGN-35T": {
    "Input Name": "SGN-35T",
    "Found": true,
    "Primary Target Name": "Tumor necrosis factor receptor superfamily member 8",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109256",
      "Preferred Name": "SGN-30",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor necrosis factor receptor superfamily member 8 agonist",
        "Action Type": "AGONIST",
        "Target ChEMBL ID": "CHEMBL2364161",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000558",
        "EFO Term": "Kaposi's sarcoma",
        "MeSH ID": "D012514",
        "MeSH Term": "Sarcoma, Kaposi",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002913",
        "EFO Term": "Cutaneous T-cell lymphoma",
        "MeSH ID": "D016410",
        "MeSH Term": "Lymphoma, T-Cell, Cutaneous",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003032",
        "EFO Term": "anaplastic large cell lymphoma",
        "MeSH ID": "D017728",
        "MeSH Term": "Lymphoma, Large-Cell, Anaplastic",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2364161",
        "Pref Name": "Tumor necrosis factor receptor superfamily member 8",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P28908",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P28908",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SGN-PDL1V": {
    "Input Name": "SGN-PDL1V",
    "Found": true,
    "Primary Target Name": "Tumor necrosis factor receptor superfamily member 8",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109256",
      "Preferred Name": "SGN-30",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tumor necrosis factor receptor superfamily member 8 agonist",
        "Action Type": "AGONIST",
        "Target ChEMBL ID": "CHEMBL2364161",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000558",
        "EFO Term": "Kaposi's sarcoma",
        "MeSH ID": "D012514",
        "MeSH Term": "Sarcoma, Kaposi",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000574",
        "EFO Term": "lymphoma",
        "MeSH ID": "D008223",
        "MeSH Term": "Lymphoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002913",
        "EFO Term": "Cutaneous T-cell lymphoma",
        "MeSH ID": "D016410",
        "MeSH Term": "Lymphoma, T-Cell, Cutaneous",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003032",
        "EFO Term": "anaplastic large cell lymphoma",
        "MeSH ID": "D017728",
        "MeSH Term": "Lymphoma, Large-Cell, Anaplastic",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2364161",
        "Pref Name": "Tumor necrosis factor receptor superfamily member 8",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P28908",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P28908",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SHR-4849": {
    "Input Name": "SHR-4849",
    "Found": true,
    "Primary Target Name": "Programmed cell death 1 ligand 1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297828",
      "Preferred Name": "SHR-1316",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Programmed cell death 1 ligand 1 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3580522",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000707",
        "EFO Term": "squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3580522",
        "Pref Name": "Programmed cell death 1 ligand 1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q9NZQ7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q9NZQ7",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SHR-A1904": {
    "Input Name": "SHR-A1904",
    "Found": true,
    "Primary Target Name": "Programmed cell death 1 ligand 1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297828",
      "Preferred Name": "SHR-1316",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Programmed cell death 1 ligand 1 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3580522",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000707",
        "EFO Term": "squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3580522",
        "Pref Name": "Programmed cell death 1 ligand 1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q9NZQ7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q9NZQ7",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SHR-A1921": {
    "Input Name": "SHR-A1921",
    "Found": true,
    "Primary Target Name": "Programmed cell death 1 ligand 1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297828",
      "Preferred Name": "SHR-1316",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Programmed cell death 1 ligand 1 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3580522",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000707",
        "EFO Term": "squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3580522",
        "Pref Name": "Programmed cell death 1 ligand 1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q9NZQ7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q9NZQ7",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SHR-A2009": {
    "Input Name": "SHR-A2009",
    "Found": true,
    "Primary Target Name": "Programmed cell death 1 ligand 1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297828",
      "Preferred Name": "SHR-1316",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Programmed cell death 1 ligand 1 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3580522",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000707",
        "EFO Term": "squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3580522",
        "Pref Name": "Programmed cell death 1 ligand 1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q9NZQ7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q9NZQ7",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SHR-A2102": {
    "Input Name": "SHR-A2102",
    "Found": true,
    "Primary Target Name": "Programmed cell death 1 ligand 1",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297828",
      "Preferred Name": "SHR-1316",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Programmed cell death 1 ligand 1 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3580522",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000702",
        "EFO Term": "small cell lung carcinoma",
        "MeSH ID": "D055752",
        "MeSH Term": "Small Cell Lung Carcinoma",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000707",
        "EFO Term": "squamous cell carcinoma",
        "MeSH ID": "D002294",
        "MeSH Term": "Carcinoma, Squamous Cell",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000182",
        "EFO Term": "hepatocellular carcinoma",
        "MeSH ID": "D006528",
        "MeSH Term": "Carcinoma, Hepatocellular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003893",
        "EFO Term": "ovarian neoplasm",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3580522",
        "Pref Name": "Programmed cell death 1 ligand 1",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "Q9NZQ7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "Q9NZQ7",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "SHR\u20111826": null,
  "SIBP-A13": null,
  "Sigvotatug vedotin": {
    "Input Name": "Sigvotatug vedotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314879",
      "Preferred Name": "SIGVOTATUG VEDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "SIM-0505": null,
  "SKB-315": null,
  "SKB-410": null,
  "SMP-656": null,
  "SOT-109": null,
  "SOT102": null,
  "STI-6129": {
    "Input Name": "STI-6129",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4802181",
      "Preferred Name": "STI-6643",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "STRO-003": null,
  "STRO-006": null,
  "STRO\u2011004": {
    "Input Name": "STRO\u2011004",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594500",
      "Preferred Name": "STRO-001",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "STRO\u2011004\u00a0": {
    "Input Name": "STRO\u2011004\u00a0",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594500",
      "Preferred Name": "STRO-001",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "SYD-3521": null,
  "SYD-4413": null,
  "SYS-6005": null,
  "SYS-6040": null,
  "TAC-001": null,
  "TB-0010": {
    "Input Name": "TB-0010",
    "Found": true,
    "Primary Target Name": "Coagulation factor VIII",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL2109410",
      "Preferred Name": "TB-402",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Coagulation factor VIII inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3143",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0004286",
        "EFO Term": "venous thromboembolism",
        "MeSH ID": "D054556",
        "MeSH Term": "Venous Thromboembolism",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3143",
        "Pref Name": "Coagulation factor VIII",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P00451",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P00451",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Telisotuzumab adizutecan": {
    "Input Name": "Telisotuzumab adizutecan",
    "Found": true,
    "Primary Target Name": "Hepatocyte growth factor receptor",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL3545419",
      "Preferred Name": "TELISOTUZUMAB",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Hepatocyte growth factor receptor inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL3717",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL3717",
        "Pref Name": "Hepatocyte growth factor receptor",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P08581",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0004714",
            "HGNC": "transmembrane receptor protein tyrosine kinase activity"
          }
        ]
      }
    ]
  },
  "TGW-101": null,
  "Tisotumab vedotin": {
    "Input Name": "Tisotumab vedotin",
    "Found": true,
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297841",
      "Preferred Name": "TISOTUMAB VEDOTIN",
      "Max Phase": "4.0",
      "First Approval": 2021,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Coagulation factor III binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL4081",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0002087",
        "EFO Term": "peritoneum cancer",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL4081",
        "Pref Name": "Coagulation factor III",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P13726",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P13726",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "TJ102": null,
  "TORL-1-23": {
    "Input Name": "TORL-1-23",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL22016",
      "Preferred Name": "ABLUKAST",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-ast",
      "Indication Class": "Anti-Asthmatic (leukotriene antagonist)"
    },
    "Mechanism of Action": [],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "TORL-2-307": null,
  "TORL-3-600": null,
  "TORL-4-5--": {
    "Input Name": "TORL-4-5--",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL291338",
      "Preferred Name": "3,3',4',5-TETRACHLOROSALICYLANILIDE",
      "Max Phase": "4.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Small molecule",
      "Withdrawn": true,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-ilide; -sal-",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Unknown",
        "Action Type": null,
        "Target ChEMBL ID": null,
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [],
    "Target Metadata": []
  },
  "TQB-2102": null,
  "TQB-2103": null,
  "Trastuzumab": {
    "Input Name": "Trastuzumab",
    "Found": true,
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1201585",
      "Preferred Name": "TRASTUZUMAB",
      "Max Phase": "4.0",
      "First Approval": 1998,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000228",
        "EFO Term": "adenocarcinoma",
        "MeSH ID": "D000230",
        "MeSH Term": "Adenocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000313",
        "EFO Term": "carcinoma",
        "MeSH ID": "D002277",
        "MeSH Term": "Carcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000501",
        "EFO Term": "follicular thyroid carcinoma",
        "MeSH ID": "D018263",
        "MeSH Term": "Adenocarcinoma, Follicular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000549",
        "EFO Term": "insulinoma",
        "MeSH ID": "D007340",
        "MeSH Term": "Insulinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000565",
        "EFO Term": "leukemia",
        "MeSH ID": "D007938",
        "MeSH Term": "Leukemia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000641",
        "EFO Term": "papillary thyroid carcinoma",
        "MeSH ID": "D013964",
        "MeSH Term": "Thyroid Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000691",
        "EFO Term": "sarcoma",
        "MeSH ID": "D012509",
        "MeSH Term": "Sarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002618",
        "EFO Term": "pancreatic carcinoma",
        "MeSH ID": "D010190",
        "MeSH Term": "Pancreatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002916",
        "EFO Term": "esophageal carcinoma",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003897",
        "EFO Term": "stomach neoplasm",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0005774",
        "EFO Term": "brain disease",
        "MeSH ID": "D001927",
        "MeSH Term": "Brain Diseases",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0006859",
        "EFO Term": "head and neck malignant neoplasia",
        "MeSH ID": "D006258",
        "MeSH Term": "Head and Neck Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006861",
        "EFO Term": "male breast carcinoma",
        "MeSH ID": "D018567",
        "MeSH Term": "Breast Neoplasms, Male",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1000028",
        "EFO Term": "ependymoma",
        "MeSH ID": "D004806",
        "MeSH Term": "Ependymoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001187",
        "EFO Term": "somatostatinoma",
        "MeSH ID": "D013005",
        "MeSH Term": "Somatostatinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001512",
        "EFO Term": "endometrial carcinoma",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009637",
        "EFO Term": "pleural effusion",
        "MeSH ID": "D010996",
        "MeSH Term": "Pleural Effusion",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000796",
        "EFO Term": "adrenal cortex carcinoma",
        "MeSH ID": "D000306",
        "MeSH Term": "Adrenal Cortex Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001051",
        "EFO Term": "mycosis fungoides",
        "MeSH ID": "D009182",
        "MeSH Term": "Mycosis Fungoides",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000432",
        "EFO Term": "breast ductal carcinoma in situ",
        "MeSH ID": "D002285",
        "MeSH Term": "Carcinoma, Intraductal, Noninfiltrating",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005221",
        "EFO Term": "cholangiocarcinoma",
        "MeSH ID": "D018281",
        "MeSH Term": "Cholangiocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006318",
        "EFO Term": "breast ductal adenocarcinoma",
        "MeSH ID": "D044584",
        "MeSH Term": "Carcinoma, Ductal",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001370",
        "EFO Term": "pericardial effusion",
        "MeSH ID": "D010490",
        "MeSH Term": "Pericardial Effusion",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001402",
        "EFO Term": "vaginal cancer",
        "MeSH ID": "D014625",
        "MeSH Term": "Vaginal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001528",
        "EFO Term": "vulva cancer",
        "MeSH ID": "D014846",
        "MeSH Term": "Vulvar Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001879",
        "EFO Term": "anus cancer",
        "MeSH ID": "D001005",
        "MeSH Term": "Anus Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002087",
        "EFO Term": "peritoneum cancer",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003196",
        "EFO Term": "appendix carcinoma",
        "MeSH ID": "D001063",
        "MeSH Term": "Appendiceal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003510",
        "EFO Term": "malignant testicular germ cell tumor",
        "MeSH ID": "D013736",
        "MeSH Term": "Testicular Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004192",
        "EFO Term": "urethra cancer",
        "MeSH ID": "D014523",
        "MeSH Term": "Urethral Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0005411",
        "EFO Term": "gallbladder cancer",
        "MeSH ID": "D005706",
        "MeSH Term": "Gallbladder Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0007576",
        "EFO Term": "esophageal cancer",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008903",
        "EFO Term": "lung cancer",
        "MeSH ID": "D008175",
        "MeSH Term": "Lung Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0021311",
        "EFO Term": "malignant tumor of parathyroid gland",
        "MeSH ID": "D010282",
        "MeSH Term": "Parathyroid Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0044926",
        "EFO Term": "oropharyngeal carcinoma",
        "MeSH ID": "D009959",
        "MeSH Term": "Oropharyngeal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0006352",
        "EFO Term": "laryngeal squamous cell carcinoma",
        "MeSH ID": "D000077195",
        "MeSH Term": "Squamous Cell Carcinoma of Head and Neck",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003060",
        "EFO Term": "biliary tract cancer",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000701",
        "EFO Term": "skin disease",
        "MeSH ID": "D012871",
        "MeSH Term": "Skin Diseases",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0008549",
        "EFO Term": "digestive system neoplasm",
        "MeSH ID": "D004067",
        "MeSH Term": "Digestive System Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0021165",
        "EFO Term": "Paget disease",
        "MeSH ID": "D010001",
        "MeSH Term": "Osteitis Deformans",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005922",
        "EFO Term": "esophageal squamous cell carcinoma",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0000521",
        "EFO Term": "salivary gland carcinoma",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0018364",
        "EFO Term": "malignant epithelial tumor of ovary",
        "MeSH ID": "D000077216",
        "MeSH Term": "Carcinoma, Ovarian Epithelial",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001663",
        "EFO Term": "prostate carcinoma",
        "MeSH ID": "D011471",
        "MeSH Term": "Prostatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003891",
        "EFO Term": "biliary tract neoplasm",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0007532",
        "EFO Term": "uterine corpus cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000294",
        "EFO Term": "HER2 Positive Breast Carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "Trastuzumab Botidotin": {
    "Input Name": "Trastuzumab Botidotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314782",
      "Preferred Name": "TRASTUZUMAB BOTIDOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Trastuzumab botisine (A166)": {
    "Input Name": "Trastuzumab botisine (A166)",
    "Found": true,
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1201585",
      "Preferred Name": "TRASTUZUMAB",
      "Max Phase": "4.0",
      "First Approval": 1998,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000228",
        "EFO Term": "adenocarcinoma",
        "MeSH ID": "D000230",
        "MeSH Term": "Adenocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000313",
        "EFO Term": "carcinoma",
        "MeSH ID": "D002277",
        "MeSH Term": "Carcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000501",
        "EFO Term": "follicular thyroid carcinoma",
        "MeSH ID": "D018263",
        "MeSH Term": "Adenocarcinoma, Follicular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000549",
        "EFO Term": "insulinoma",
        "MeSH ID": "D007340",
        "MeSH Term": "Insulinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000565",
        "EFO Term": "leukemia",
        "MeSH ID": "D007938",
        "MeSH Term": "Leukemia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000641",
        "EFO Term": "papillary thyroid carcinoma",
        "MeSH ID": "D013964",
        "MeSH Term": "Thyroid Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000691",
        "EFO Term": "sarcoma",
        "MeSH ID": "D012509",
        "MeSH Term": "Sarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002618",
        "EFO Term": "pancreatic carcinoma",
        "MeSH ID": "D010190",
        "MeSH Term": "Pancreatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002916",
        "EFO Term": "esophageal carcinoma",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003897",
        "EFO Term": "stomach neoplasm",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0005774",
        "EFO Term": "brain disease",
        "MeSH ID": "D001927",
        "MeSH Term": "Brain Diseases",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0006859",
        "EFO Term": "head and neck malignant neoplasia",
        "MeSH ID": "D006258",
        "MeSH Term": "Head and Neck Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006861",
        "EFO Term": "male breast carcinoma",
        "MeSH ID": "D018567",
        "MeSH Term": "Breast Neoplasms, Male",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1000028",
        "EFO Term": "ependymoma",
        "MeSH ID": "D004806",
        "MeSH Term": "Ependymoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001187",
        "EFO Term": "somatostatinoma",
        "MeSH ID": "D013005",
        "MeSH Term": "Somatostatinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001512",
        "EFO Term": "endometrial carcinoma",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009637",
        "EFO Term": "pleural effusion",
        "MeSH ID": "D010996",
        "MeSH Term": "Pleural Effusion",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000796",
        "EFO Term": "adrenal cortex carcinoma",
        "MeSH ID": "D000306",
        "MeSH Term": "Adrenal Cortex Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001051",
        "EFO Term": "mycosis fungoides",
        "MeSH ID": "D009182",
        "MeSH Term": "Mycosis Fungoides",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000432",
        "EFO Term": "breast ductal carcinoma in situ",
        "MeSH ID": "D002285",
        "MeSH Term": "Carcinoma, Intraductal, Noninfiltrating",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005221",
        "EFO Term": "cholangiocarcinoma",
        "MeSH ID": "D018281",
        "MeSH Term": "Cholangiocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006318",
        "EFO Term": "breast ductal adenocarcinoma",
        "MeSH ID": "D044584",
        "MeSH Term": "Carcinoma, Ductal",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001370",
        "EFO Term": "pericardial effusion",
        "MeSH ID": "D010490",
        "MeSH Term": "Pericardial Effusion",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001402",
        "EFO Term": "vaginal cancer",
        "MeSH ID": "D014625",
        "MeSH Term": "Vaginal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001528",
        "EFO Term": "vulva cancer",
        "MeSH ID": "D014846",
        "MeSH Term": "Vulvar Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001879",
        "EFO Term": "anus cancer",
        "MeSH ID": "D001005",
        "MeSH Term": "Anus Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002087",
        "EFO Term": "peritoneum cancer",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003196",
        "EFO Term": "appendix carcinoma",
        "MeSH ID": "D001063",
        "MeSH Term": "Appendiceal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003510",
        "EFO Term": "malignant testicular germ cell tumor",
        "MeSH ID": "D013736",
        "MeSH Term": "Testicular Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004192",
        "EFO Term": "urethra cancer",
        "MeSH ID": "D014523",
        "MeSH Term": "Urethral Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0005411",
        "EFO Term": "gallbladder cancer",
        "MeSH ID": "D005706",
        "MeSH Term": "Gallbladder Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0007576",
        "EFO Term": "esophageal cancer",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008903",
        "EFO Term": "lung cancer",
        "MeSH ID": "D008175",
        "MeSH Term": "Lung Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0021311",
        "EFO Term": "malignant tumor of parathyroid gland",
        "MeSH ID": "D010282",
        "MeSH Term": "Parathyroid Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0044926",
        "EFO Term": "oropharyngeal carcinoma",
        "MeSH ID": "D009959",
        "MeSH Term": "Oropharyngeal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0006352",
        "EFO Term": "laryngeal squamous cell carcinoma",
        "MeSH ID": "D000077195",
        "MeSH Term": "Squamous Cell Carcinoma of Head and Neck",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003060",
        "EFO Term": "biliary tract cancer",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000701",
        "EFO Term": "skin disease",
        "MeSH ID": "D012871",
        "MeSH Term": "Skin Diseases",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0008549",
        "EFO Term": "digestive system neoplasm",
        "MeSH ID": "D004067",
        "MeSH Term": "Digestive System Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0021165",
        "EFO Term": "Paget disease",
        "MeSH ID": "D010001",
        "MeSH Term": "Osteitis Deformans",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005922",
        "EFO Term": "esophageal squamous cell carcinoma",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0000521",
        "EFO Term": "salivary gland carcinoma",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0018364",
        "EFO Term": "malignant epithelial tumor of ovary",
        "MeSH ID": "D000077216",
        "MeSH Term": "Carcinoma, Ovarian Epithelial",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001663",
        "EFO Term": "prostate carcinoma",
        "MeSH ID": "D011471",
        "MeSH Term": "Prostatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003891",
        "EFO Term": "biliary tract neoplasm",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0007532",
        "EFO Term": "uterine corpus cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000294",
        "EFO Term": "HER2 Positive Breast Carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "Trastuzumab deruxtecan": {
    "Input Name": "Trastuzumab deruxtecan",
    "Found": true,
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297844",
      "Preferred Name": "TRASTUZUMAB DERUXTECAN",
      "Max Phase": "4.0",
      "First Approval": 2019,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA topoisomerase I inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1781",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0008549",
        "EFO Term": "digestive system neoplasm",
        "MeSH ID": "D004067",
        "MeSH Term": "Digestive System Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005842",
        "EFO Term": "colorectal cancer",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1781",
        "Pref Name": "DNA topoisomerase I",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P11387",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P11387",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "Trastuzumab duocarmazine": {
    "Input Name": "Trastuzumab duocarmazine",
    "Found": true,
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4298178",
      "Preferred Name": "TRASTUZUMAB DUOCARMAZINE",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "DNA disrupting agent",
        "Action Type": "DISRUPTING AGENT",
        "Target ChEMBL ID": "CHEMBL2311221",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001075",
        "EFO Term": "ovarian carcinoma",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0004243",
        "EFO Term": "carcinoid tumor",
        "MeSH ID": "D002276",
        "MeSH Term": "Carcinoid Tumor",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0021251",
        "EFO Term": "endometrium neoplasm",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL2311221",
        "Pref Name": "DNA",
        "Target Type": "NUCLEIC-ACID",
        "Organism": "Homo sapiens",
        "Target Components": []
      }
    ]
  },
  "Trastuzumab emtansine": {
    "Input Name": "Trastuzumab emtansine",
    "Found": true,
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1743082",
      "Preferred Name": "TRASTUZUMAB EMTANSINE",
      "Max Phase": "4.0",
      "First Approval": 2013,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tansine",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0001378",
        "EFO Term": "multiple myeloma",
        "MeSH ID": "D009101",
        "MeSH Term": "Multiple Myeloma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0000521",
        "EFO Term": "salivary gland carcinoma",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000294",
        "EFO Term": "HER2 Positive Breast Carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "Trastuzumab pamirtecan": {
    "Input Name": "Trastuzumab pamirtecan",
    "Found": true,
    "Primary Target Name": "Receptor protein-tyrosine kinase erbB-2",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL1201585",
      "Preferred Name": "TRASTUZUMAB",
      "Max Phase": "4.0",
      "First Approval": 1998,
      "Drug Type": null,
      "Molecule Type": "Antibody",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000228",
        "EFO Term": "adenocarcinoma",
        "MeSH ID": "D000230",
        "MeSH Term": "Adenocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000305",
        "EFO Term": "breast carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000313",
        "EFO Term": "carcinoma",
        "MeSH ID": "D002277",
        "MeSH Term": "Carcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000222",
        "EFO Term": "acute myeloid leukemia",
        "MeSH ID": "D015470",
        "MeSH Term": "Leukemia, Myeloid, Acute",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000501",
        "EFO Term": "follicular thyroid carcinoma",
        "MeSH ID": "D018263",
        "MeSH Term": "Adenocarcinoma, Follicular",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000503",
        "EFO Term": "gastric adenocarcinoma",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0000549",
        "EFO Term": "insulinoma",
        "MeSH ID": "D007340",
        "MeSH Term": "Insulinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000565",
        "EFO Term": "leukemia",
        "MeSH ID": "D007938",
        "MeSH Term": "Leukemia",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000637",
        "EFO Term": "osteosarcoma",
        "MeSH ID": "D012516",
        "MeSH Term": "Osteosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000641",
        "EFO Term": "papillary thyroid carcinoma",
        "MeSH ID": "D013964",
        "MeSH Term": "Thyroid Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000691",
        "EFO Term": "sarcoma",
        "MeSH ID": "D012509",
        "MeSH Term": "Sarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002618",
        "EFO Term": "pancreatic carcinoma",
        "MeSH ID": "D010190",
        "MeSH Term": "Pancreatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0002916",
        "EFO Term": "esophageal carcinoma",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003863",
        "EFO Term": "urogenital neoplasm",
        "MeSH ID": "D014565",
        "MeSH Term": "Urogenital Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003897",
        "EFO Term": "stomach neoplasm",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "EFO:0005774",
        "EFO Term": "brain disease",
        "MeSH ID": "D001927",
        "MeSH Term": "Brain Diseases",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005952",
        "EFO Term": "non-Hodgkins lymphoma",
        "MeSH ID": "D008228",
        "MeSH Term": "Lymphoma, Non-Hodgkin",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0006859",
        "EFO Term": "head and neck malignant neoplasia",
        "MeSH ID": "D006258",
        "MeSH Term": "Head and Neck Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006861",
        "EFO Term": "male breast carcinoma",
        "MeSH ID": "D018567",
        "MeSH Term": "Breast Neoplasms, Male",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1000028",
        "EFO Term": "ependymoma",
        "MeSH ID": "D004806",
        "MeSH Term": "Ependymoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1000984",
        "EFO Term": "inflammatory breast carcinoma",
        "MeSH ID": "D058922",
        "MeSH Term": "Inflammatory Breast Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:1001187",
        "EFO Term": "somatostatinoma",
        "MeSH ID": "D013005",
        "MeSH Term": "Somatostatinoma",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001512",
        "EFO Term": "endometrial carcinoma",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1001951",
        "EFO Term": "colorectal carcinoma",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000183",
        "EFO Term": "Hodgkins lymphoma",
        "MeSH ID": "D006689",
        "MeSH Term": "Hodgkin Disease",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009637",
        "EFO Term": "pleural effusion",
        "MeSH ID": "D010996",
        "MeSH Term": "Pleural Effusion",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0009708",
        "EFO Term": "metastasis",
        "MeSH ID": "D009362",
        "MeSH Term": "Neoplasm Metastasis",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000796",
        "EFO Term": "adrenal cortex carcinoma",
        "MeSH ID": "D000306",
        "MeSH Term": "Adrenal Cortex Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001051",
        "EFO Term": "mycosis fungoides",
        "MeSH ID": "D009182",
        "MeSH Term": "Mycosis Fungoides",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0000432",
        "EFO Term": "breast ductal carcinoma in situ",
        "MeSH ID": "D002285",
        "MeSH Term": "Carcinoma, Intraductal, Noninfiltrating",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005221",
        "EFO Term": "cholangiocarcinoma",
        "MeSH ID": "D018281",
        "MeSH Term": "Cholangiocarcinoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0006318",
        "EFO Term": "breast ductal adenocarcinoma",
        "MeSH ID": "D044584",
        "MeSH Term": "Carcinoma, Ductal",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001056",
        "EFO Term": "gastric cancer",
        "MeSH ID": "D013274",
        "MeSH Term": "Stomach Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0001187",
        "EFO Term": "urinary bladder cancer",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0001370",
        "EFO Term": "pericardial effusion",
        "MeSH ID": "D010490",
        "MeSH Term": "Pericardial Effusion",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001402",
        "EFO Term": "vaginal cancer",
        "MeSH ID": "D014625",
        "MeSH Term": "Vaginal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001528",
        "EFO Term": "vulva cancer",
        "MeSH ID": "D014846",
        "MeSH Term": "Vulvar Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0001879",
        "EFO Term": "anus cancer",
        "MeSH ID": "D001005",
        "MeSH Term": "Anus Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002087",
        "EFO Term": "peritoneum cancer",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003196",
        "EFO Term": "appendix carcinoma",
        "MeSH ID": "D001063",
        "MeSH Term": "Appendiceal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003510",
        "EFO Term": "malignant testicular germ cell tumor",
        "MeSH ID": "D013736",
        "MeSH Term": "Testicular Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0004192",
        "EFO Term": "urethra cancer",
        "MeSH ID": "D014523",
        "MeSH Term": "Urethral Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004669",
        "EFO Term": "salivary gland cancer",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0005411",
        "EFO Term": "gallbladder cancer",
        "MeSH ID": "D005706",
        "MeSH Term": "Gallbladder Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0007576",
        "EFO Term": "esophageal cancer",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008315",
        "EFO Term": "prostate cancer",
        "MeSH ID": "D064129",
        "MeSH Term": "Prostatic Neoplasms, Castration-Resistant",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0008903",
        "EFO Term": "lung cancer",
        "MeSH ID": "D008175",
        "MeSH Term": "Lung Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0011962",
        "EFO Term": "endometrial cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0021311",
        "EFO Term": "malignant tumor of parathyroid gland",
        "MeSH ID": "D010282",
        "MeSH Term": "Parathyroid Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0044926",
        "EFO Term": "oropharyngeal carcinoma",
        "MeSH ID": "D009959",
        "MeSH Term": "Oropharyngeal Neoplasms",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0006352",
        "EFO Term": "laryngeal squamous cell carcinoma",
        "MeSH ID": "D000077195",
        "MeSH Term": "Squamous Cell Carcinoma of Head and Neck",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0003060",
        "EFO Term": "biliary tract cancer",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0000701",
        "EFO Term": "skin disease",
        "MeSH ID": "D012871",
        "MeSH Term": "Skin Diseases",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0008549",
        "EFO Term": "digestive system neoplasm",
        "MeSH ID": "D004067",
        "MeSH Term": "Digestive System Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0021165",
        "EFO Term": "Paget disease",
        "MeSH ID": "D010001",
        "MeSH Term": "Osteitis Deformans",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0004142",
        "EFO Term": "colorectal neoplasm",
        "MeSH ID": "D015179",
        "MeSH Term": "Colorectal Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005922",
        "EFO Term": "esophageal squamous cell carcinoma",
        "MeSH ID": "D004938",
        "MeSH Term": "Esophageal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0000521",
        "EFO Term": "salivary gland carcinoma",
        "MeSH ID": "D012468",
        "MeSH Term": "Salivary Gland Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004986",
        "EFO Term": "urinary bladder carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0018364",
        "EFO Term": "malignant epithelial tumor of ovary",
        "MeSH ID": "D000077216",
        "MeSH Term": "Carcinoma, Ovarian Epithelial",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:0001642",
        "EFO Term": "lymphoid neoplasm",
        "MeSH ID": "D019337",
        "MeSH Term": "Hematologic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0001663",
        "EFO Term": "prostate carcinoma",
        "MeSH ID": "D011471",
        "MeSH Term": "Prostatic Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003891",
        "EFO Term": "biliary tract neoplasm",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "EFO:0007532",
        "EFO Term": "uterine corpus cancer",
        "MeSH ID": "D016889",
        "MeSH Term": "Endometrial Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:1000294",
        "EFO Term": "HER2 Positive Breast Carcinoma",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "Trastuzumab rezetecan": {
    "Input Name": "Trastuzumab rezetecan",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5314712",
      "Preferred Name": "TRASTUZUMAB REZETECAN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-mab; -tecan",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "Trastuzumab vedotin": {
    "Input Name": "Trastuzumab vedotin",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL5315030",
      "Preferred Name": "TRASTUZUMAB VEDOTIN",
      "Max Phase": "3.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003060",
        "EFO Term": "non-small cell lung carcinoma",
        "MeSH ID": "D002289",
        "MeSH Term": "Carcinoma, Non-Small-Cell Lung",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0008528",
        "EFO Term": "urothelial carcinoma",
        "MeSH ID": "D001749",
        "MeSH Term": "Urinary Bladder Neoplasms",
        "Max Phase for Indication": "3.0"
      },
      {
        "EFO ID": "MONDO:0003060",
        "EFO Term": "biliary tract cancer",
        "MeSH ID": "D001661",
        "MeSH Term": "Biliary Tract Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": []
  },
  "TROL-4-500": null,
  "TRPH-222": {
    "Input Name": "TRPH-222",
    "Found": true,
    "Primary Target Name": null,
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4594508",
      "Preferred Name": "TRPH-222",
      "Max Phase": "1.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Unknown",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": null,
      "Indication Class": null
    },
    "Mechanism of Action": [],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000403",
        "EFO Term": "diffuse large B-cell lymphoma",
        "MeSH ID": "D016403",
        "MeSH Term": "Lymphoma, Large B-Cell, Diffuse",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "EFO:1001469",
        "EFO Term": "Mantle cell lymphoma",
        "MeSH ID": "D020522",
        "MeSH Term": "Lymphoma, Mantle-Cell",
        "Max Phase for Indication": "1.0"
      },
      {
        "EFO ID": "MONDO:0018906",
        "EFO Term": "follicular lymphoma",
        "MeSH ID": "D008224",
        "MeSH Term": "Lymphoma, Follicular",
        "Max Phase for Indication": "1.0"
      }
    ],
    "Target Metadata": []
  },
  "TRS-005": null,
  "TUB-040": null,
  "Tub\u2010030": null,
  "VIP-943": null,
  "XB-010": null,
  "XMT-2056": null,
  "XNW-28012": null,
  "YH-013": null,
  "YL-201": null,
  "YL-202": null,
  "YL-205": null,
  "YL-211": null,
  "Zilovertamab vedotin": {
    "Input Name": "Zilovertamab vedotin",
    "Found": true,
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297841",
      "Preferred Name": "TISOTUMAB VEDOTIN",
      "Max Phase": "4.0",
      "First Approval": 2021,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 1,
      "ATC Codes": [],
      "USAN Stem": "-dotin; -mab",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Coagulation factor III binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL4081",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0002087",
        "EFO Term": "peritoneum cancer",
        "MeSH ID": "D010534",
        "MeSH Term": "Peritoneal Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0002158",
        "EFO Term": "fallopian tube cancer",
        "MeSH ID": "D005185",
        "MeSH Term": "Fallopian Tube Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0002974",
        "EFO Term": "cervical cancer",
        "MeSH ID": "D002583",
        "MeSH Term": "Uterine Cervical Neoplasms",
        "Max Phase for Indication": "4.0"
      },
      {
        "EFO ID": "MONDO:0008170",
        "EFO Term": "ovarian cancer",
        "MeSH ID": "D010051",
        "MeSH Term": "Ovarian Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "4.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL4081",
        "Pref Name": "Coagulation factor III",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P13726",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "P13726",
            "HGNC": null
          }
        ]
      }
    ]
  },
  "ZL-1310": null,
  "ZW-191": null,
  "ZW-220": null,
  "ZW-251": null,
  "SH-A1811": null,
  "MRG-002": null,
  "SYD-985": null,
  "ARX788": {
    "Input Name": "ARX788",
    "Found": true,
    "Primary Target Name": "Tubulin",
    "Molecule Info": {
      "ChEMBL ID": "CHEMBL4297892",
      "Preferred Name": "ANVATABART OPADOTIN",
      "Max Phase": "2.0",
      "First Approval": null,
      "Drug Type": null,
      "Molecule Type": "Antibody drug conjugate",
      "Withdrawn": false,
      "Black Box Warning": 0,
      "ATC Codes": [],
      "USAN Stem": "-dotin",
      "Indication Class": null
    },
    "Mechanism of Action": [
      {
        "Mechanism of Action": "Tubulin inhibitor",
        "Action Type": "INHIBITOR",
        "Target ChEMBL ID": "CHEMBL2095182",
        "Disease Efficacy": 1
      },
      {
        "Mechanism of Action": "Receptor protein-tyrosine kinase erbB-2 binding agent",
        "Action Type": "BINDING AGENT",
        "Target ChEMBL ID": "CHEMBL1824",
        "Disease Efficacy": 1
      }
    ],
    "Drug Indications": [
      {
        "EFO ID": "EFO:0003869",
        "EFO Term": "breast neoplasm",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0007254",
        "EFO Term": "breast cancer",
        "MeSH ID": "D001943",
        "MeSH Term": "Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0000616",
        "EFO Term": "neoplasm",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0003968",
        "EFO Term": "angiosarcoma",
        "MeSH ID": "D006394",
        "MeSH Term": "Hemangiosarcoma",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "EFO:0005537",
        "EFO Term": "triple-negative breast cancer",
        "MeSH ID": "D064726",
        "MeSH Term": "Triple Negative Breast Neoplasms",
        "Max Phase for Indication": "2.0"
      },
      {
        "EFO ID": "MONDO:0004992",
        "EFO Term": "cancer",
        "MeSH ID": "D009369",
        "MeSH Term": "Neoplasms",
        "Max Phase for Indication": "2.0"
      }
    ],
    "Target Metadata": [
      {
        "Target ChEMBL ID": "CHEMBL2095182",
        "Pref Name": "Tubulin",
        "Target Type": "PROTEIN COMPLEX GROUP",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P68371",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9H4B7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P0DPH7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "P68366",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13509",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q71U36",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0036126",
            "HGNC": "sperm flagellum"
          },
          {
            "Accession": "P04350",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q3ZCM7",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "P07437",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0071895",
            "HGNC": "odontoblast differentiation"
          },
          {
            "Accession": "P68363",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003725",
            "HGNC": "double-stranded RNA binding"
          },
          {
            "Accession": "Q9BQE3",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005198",
            "HGNC": "structural molecule activity"
          },
          {
            "Accession": "Q6PEY2",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0005200",
            "HGNC": "structural constituent of cytoskeleton"
          },
          {
            "Accession": "Q13885",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BVA1",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          },
          {
            "Accession": "Q9BUF5",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0003924",
            "HGNC": "GTPase activity"
          }
        ]
      },
      {
        "Target ChEMBL ID": "CHEMBL1824",
        "Pref Name": "Receptor protein-tyrosine kinase erbB-2",
        "Target Type": "SINGLE PROTEIN",
        "Organism": "Homo sapiens",
        "Target Components": [
          {
            "Accession": "P04626",
            "Component Type": "PROTEIN",
            "Organism": null,
            "UniProt": "GO:0007166",
            "HGNC": "cell surface receptor signaling pathway"
          }
        ]
      }
    ]
  },
  "BSI730": null,
  "YH-012": null,
  "GenSci139": null
}